Association of Research-Based Pharmaceutical Companies (AİFD) was established in 2003, by research-based pharmaceutical companies operating in Turkey, with the objective of enabling Turkish people access new and original drugs and providing effective solutions to the health conditions in our country. AİFD pursues its activities through its head office in Istanbul and its representative office in Ankara. AİFD members focus their efforts on innovation, with the awareness that innovative and original products, developed upon benefiting from the opportunities offered in various fields, such as biogenetics, by the rapidly advancing medical science in our era, extend longevity of humans, enhance their quality of life and generate a value for the society. They work on the basis of integrity, transparency and accountability.
AİFD members strive to fulfill all their responsibilities towards the society, placing a priority on the enhancement of the quality of life of Turkish people and presenting solutions to their health conditions. Our Vision To act as a “solution partner” for the healthcare sector and government in Turkey with regard to the difficulties encountered in healthcare, by providing “innovative therapeutic solutions” Our Mission To contribute to the healthcare sector in Turkey, by enhancing access to “innovative” products, technology and information in the Turkish medical field and creating an “ethical and transparent” environment in the healthcare sector.
Contact Details
AİFD Office İstanbul
Barboros Bulvarı No:149
TEV Orhan Birman İş Merkezi
Balmumcu-Istanbul
Turkey
Tel: (0212) 267 16 00(pbx)
Fax: (0212) 273 11 79
aifd@aifd.org.tr
AİFD Office Ankara
Söğütözü Mahallesi 2176.
Sokak Platin Tower No:7
Kat:14 Daire:52-55
Çankaya/Ankara Türkiye
Tel: (0312) 425 49 77
Fax: (0312) 425 49 27
aifd@aifd.org.tr
The secretary general of the innovators’ association gives an overview of the current structural challenges facing the pharmaceutical industry in Turkey, and discusses the changes that need to be introduced…
As the international community continues its quest to vaccinate the global population against COVID-19, shortages of already approved vaccines have put many countries on the waiting list. Approved vaccines from…
Ümit Dereli is secretary general of the Turkish Association of Research-Based Pharmaceutical Companies (AIFD), which has 35 multinational member companies that together account for almost 50 percent of the Turkish…
When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a historic moment for Turkey’s pharma industry; the first time a Turkish…
There is perhaps no Turkish company in the healthcare sector that is more ambitious than Acıbadem. Not only has the private hospital group revolutionized healthcare in Turkey with its advanced…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his experience working for the largest biotech in the MENA region, Turkey’s important role within the global group, and…
Şükran Tümay, a senior partner at executive search and assessment firm Stanton Chase in Turkey, highlights the evolving profiles she looks for when hiring country managers for healthcare and the…
Turkey – home to an 80 million-strong population, a substantial pharmaceuticals market and a universal healthcare system that is the envy of its neighbours – stands as one of the…
Bucking a global trend for increased focus on outpatient and preventative care, Turkey is doubling down on hospital investment. Throughout many of the healthcare systems in North America and Europe, there…
Armağan Vurdu, general secretary of the Istanbul Minerals and Metals Exporters Association (IMMIB) highlights the strategic importance of the chemical and pharmaceutical sectors in Turkey’s exports. He underscores pharma’s role…
Ozlem Fidanci, CEO of the Middle East and Turkey at Philips, shares the collaborative approach Philips has implemented in Turkey and its successes, provides insights into future collaborations and discusses…
Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the strengths of the Turkish PPP model and ultimately…
Seizing the cost competitiveness of the Turkish market and the government’s nurturing of local manufacturing, Turkish companies are looking to harness their geographic positioning and export to developed and developing…
See our Cookie Privacy Policy Here
